Blockbuster deal sends Northern California industrial hub to top of new investment report

Lonza completed its acquisition of the Genentech biologics manufacturing site in Vacaville, California, in October for $1.2 billion. (Lonza)
CBRE lists Vallejo/Fairfield as number one market for recent net lease sales